Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Geburtshilfe Und Frauenheilkunde|March 1, 1984
[Effect and adverse effects of epidural anesthesia during labor. With special reference to changes in the cardiotocogram]K Baumgarten, T Neubauer, B Bartosch, et al.
Geburtshilfe Und Frauenheilkunde|February 1, 1982
[The efficacy of oral betamimetics using an oxytocin-stimulated puerperal model (author's transl)]K Baumgarten, W Lingard, A Horvat, et al.
Wiener Klinische Wochenschrift|October 24, 1986
[Incidence of Chlamydia trachomatis infections in pregnant patients in Vienna]B Niebauer, J Söltz-Szöts, K Baumgarten, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|November 1, 1983
13,14-Dihydro-15-keto-PGF2 alpha (PGFM) and sulprostone serum levels after application of sulprostone to postpartum womenJ Spona, K Baumgarten, J Schmidt, et al.
JAMA|June 13, 1990
Success of reentry into anesthesiology training programs by residents with a history of substance abuseE J Menk, R K Baumgarten, C P Kingsley, et al.
The Journal of Biological Chemistry|September 20, 2001
The plasma membrane-associated protein RS1 decreases transcription of the transporter SGLT1 in confluent LLC-PK1 cellsT Korn, T Kühlkamp, C Track, et al.
Thrombosis and Haemostasis|January 1, 1994
The prevalence of moderate and severe FXII (Hageman factor) deficiency among the normal population: evaluation of the incidence of FXII deficiency among 300 healthy blood donorsW M Halbmayer, A Haushofer, R Schön, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|January 1, 1988
Priming with nondepolarizing relaxants for rapid tracheal intubation: a double-blind evaluationR K Baumgarten, C E Carter, W J Reynolds, et al.
Geburtshilfe Und Frauenheilkunde|November 1, 1985
[Results of the first Austrian multicenter ovarian cancer study: prospective randomized comparison of sequential chemotherapy (adriamycin/cisplatin--vincristine/cyclophosphamide--methotrexate) with 2 standard protocols (adriamycin/cyclophosphamide or adriamycin/cisplatin) in stage III and IV patients]H Salzer, E Gitsch, C Dittrich, et al.
Annals of Hematology|April 1, 1995
Risk of human immunodeficiency virus (HIV) transmission by anti-HIV-negative blood components in Germany and AustriaD W Schwartz, G Simson, K Baumgarten, et al.
Pageof 9